CLINICAL ASPECTS OF FUNGAL INFECTION IN ORGAN TRANSPLANT RECIPIENTS

被引:90
作者
HIBBERD, PL
RUBIN, RH
机构
[1] MASSACHUSETTS GEN HOSP,TRANSPLANT UNIT,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA
[3] HARVARD UNIV,MIT,CTR EXPTL PHARMACOL & THERAPEUT,DIV HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139
关键词
D O I
10.1093/clinids/19.Supplement_1.S33
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fungal infections following solid organ transplantation remain a major cause of morbidity and mortality. Candida species and Aspergillus fumigatus continue to account for the majority of these infections, although the attack rate is higher among recipients of organs other than kidneys because those patients receive more immunosuppressive therapy. Although amphotericin B remains the drug of choice for treatment of invasive aspergillosis, its toxicity profile limits its widespread use. Recent experience suggests that fluconazole may be a safe and effective alternative for the treatment of fungal infections caused by Candida species or Cryptococcus neoformans. Prevention of fungal infections remains one of the most important goals in the field of transplantation. New approaches-such as the use of ''preemptive therapy,'' or prophylaxis, for patients at greatest risk of developing infection-may assist in attainment of this goal.
引用
收藏
页码:S33 / S40
页数:8
相关论文
共 65 条
  • [41] TRANSMISSION OF CANDIDA-ALBICANS BY CADAVERIC ALLOGRAFTS
    MCLEISH, KR
    MCMURRAY, SD
    SMITH, EJ
    FILO, RS
    [J]. JOURNAL OF UROLOGY, 1977, 118 (04) : 513 - 516
  • [42] CURRENT ROLE OF THERAPY WITH AMPHOTERICIN-B
    MEYER, RD
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 : S154 - S160
  • [43] MEYER RD, 1991, REV INFECT DIS, V13, P513
  • [44] NEUROPATHOLOGY OF HEART-TRANSPLANTATION - 23 CASES
    MONTERO, CG
    MARTINEZ, AJ
    [J]. NEUROLOGY, 1986, 36 (09) : 1149 - 1154
  • [45] SURVIVAL OF A PATIENT TRANSPLANTED WITH A KIDNEY INFECTED WITH CRYPTOCOCCUS-NEOFORMANS
    OOI, BS
    CHEN, BTM
    LIM, CH
    KHOO, OT
    CHAN, KT
    [J]. TRANSPLANTATION, 1971, 11 (04) : 428 - &
  • [46] OWENS JL, 1979, TRANSPLANTATION, V27, P285
  • [47] INCIDENCE, DISTRIBUTION, AND OUTCOME OF EPISODES OF INFECTION IN 100 ORTHOTOPIC LIVER TRANSPLANTATIONS
    PAYA, CV
    HERMANS, PE
    WASHINGTON, JA
    SMITH, TF
    ANHALT, JP
    WIESNER, RH
    KROM, RAF
    [J]. MAYO CLINIC PROCEEDINGS, 1989, 64 (05) : 555 - 564
  • [48] PANCREAS TRANSPLANTATION AT MAYO .3. MULTIDISCIPLINARY MANAGEMENT
    PERKINS, JD
    FROHNERT, PP
    SERVICE, FJ
    WILHELM, MP
    KEATING, MR
    DICECCO, SR
    JOHNSON, JL
    MUNN, SR
    VELOSA, JA
    [J]. MAYO CLINIC PROCEEDINGS, 1990, 65 (04) : 496 - 508
  • [49] CYTOMEGALO-VIRUS DISEASE IN RENAL-ALLOGRAFT RECIPIENTS - A PROSPECTIVE-STUDY OF THE CLINICAL-FEATURES, RISK-FACTORS AND IMPACT ON RENAL-TRANSPLANTATION
    PETERSON, PK
    BALFOUR, HH
    MARKER, SC
    FRYD, DS
    HOWARD, RJ
    SIMMONS, RL
    [J]. MEDICINE, 1980, 59 (04) : 283 - 300
  • [50] REX JH, 1993, 33RD INT C ANT AG CH